Telomir Pharmaceuticals Stock Forward View - Accumulation Distribution
| TELO Stock | 1.09 0.01 0.93% |
Telomir Stock outlook is based on your current time horizon. Although Telomir Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Telomir Pharmaceuticals' systematic risk associated with finding meaningful patterns of Telomir Pharmaceuticals fundamentals over time.
As of today the relative strength index (rsi) of Telomir Pharmaceuticals' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.07) | EPS Estimate Current Year (0.38) | EPS Estimate Next Year (0.28) | Wall Street Target Price 15.5 |
Using Telomir Pharmaceuticals hype-based prediction, you can estimate the value of Telomir Pharmaceuticals Common from the perspective of Telomir Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Telomir Pharmaceuticals after-hype prediction price | USD 1.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Telomir Pharmaceuticals to cross-verify your projections. Telomir Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Telomir price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Telomir using various technical indicators. When you analyze Telomir charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3667.77 | 0.0536 |
| Check Telomir Pharmaceuticals Volatility | Backtest Telomir Pharmaceuticals | Information Ratio |
Telomir Pharmaceuticals Trading Date Momentum
| On February 15 2026 Telomir Pharmaceuticals Common was traded for 1.09 at the closing time. The top price for the day was 1.12 and the lowest listed price was 1.06 . There was no trading activity during the period 0.0. Lack of trading volume on February 15, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.92% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Telomir Pharmaceuticals to competition |
Other Forecasting Options for Telomir Pharmaceuticals
For every potential investor in Telomir, whether a beginner or expert, Telomir Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Telomir Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Telomir. Basic forecasting techniques help filter out the noise by identifying Telomir Pharmaceuticals' price trends.Telomir Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Telomir Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Telomir Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Telomir Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Telomir Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Telomir Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telomir Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Telomir Pharmaceuticals stock market strength indicators, traders can identify Telomir Pharmaceuticals Common entry and exit signals to maximize returns.
Telomir Pharmaceuticals Risk Indicators
The analysis of Telomir Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Telomir Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting telomir stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.64 | |||
| Standard Deviation | 3.39 | |||
| Variance | 11.48 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Telomir Pharmaceuticals
The number of cover stories for Telomir Pharmaceuticals depends on current market conditions and Telomir Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Telomir Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Telomir Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Telomir Pharmaceuticals Short Properties
Telomir Pharmaceuticals' future price predictability will typically decrease when Telomir Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Telomir Pharmaceuticals Common often depends not only on the future outlook of the potential Telomir Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telomir Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.5 M | |
| Cash And Short Term Investments | 1.3 M |
Check out Historical Fundamental Analysis of Telomir Pharmaceuticals to cross-verify your projections. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Pharmaceuticals sector continue expanding? Could Telomir diversify its offerings? Factors like these will boost the valuation of Telomir Pharmaceuticals. If investors know Telomir will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Telomir Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Telomir Pharmaceuticals is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Telomir Pharmaceuticals' market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Telomir Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.